Jeff Yass’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.7M | Sell |
133,673
-16,856
| -11% | -$6.25M | ﹤0.01% | 1479 |
|
|
2026
Q1 | $44.1M | Buy |
150,529
+22,176
| +17% | +$7.29M | ﹤0.01% | 1391 |
|
|
2025
Q4 | $45M | Sell |
128,353
-62,714
| -33% | -$21.2M | 0.01% | 1449 |
|
|
2025
Q3 | $61.7M | Buy |
191,067
+52,193
| +38% | +$16.2M | 0.01% | 1200 |
|
|
2025
Q2 | $54M | Buy |
138,874
+37,755
| +37% | +$15.2M | 0.01% | 1112 |
|
|
2025
Q1 | $44M | Sell |
101,119
-57,832
| -36% | -$23.2M | 0.01% | 1104 |
|
|
2024
Q4 | $58.6M | Buy |
158,951
+128,519
| +422% | +$53.8M | 0.01% | 1000 |
|
|
2024
Q3 | $15.8M | Sell |
30,432
-38,898
| -56% | -$20.8M | ﹤0.01% | 2068 |
|
|
2024
Q2 | $37.6M | Sell |
69,330
-4,023
| -5% | -$2.13M | 0.01% | 1193 |
|
|
2024
Q1 | $38M | Sell |
73,353
-42,469
| -37% | -$21.1M | 0.01% | 1222 |
|
|
2023
Q4 | $54.6M | Buy |
115,822
+9,462
| +9% | +$4.38M | 0.01% | 982 |
|
|
2023
Q3 | $46.3M | Sell |
106,360
-102,489
| -49% | -$46.5M | 0.01% | 1055 |
|
|
2023
Q2 | $92.8M | Buy |
208,849
+65,495
| +46% | +$30.2M | 0.02% | 650 |
|
|
2023
Q1 | $65.9M | Buy |
143,354
+48,100
| +50% | +$22.9M | 0.01% | 791 |
|
|
2022
Q4 | $48.9M | Buy |
95,254
+89,932
| +1,690% | +$45.7M | 0.01% | 892 |
|
|
2022
Q3 | $2.42M | Sell |
5,322
-64,226
| -92% | -$30.7M | ﹤0.01% | 4544 |
|
|
2022
Q2 | $33.6M | Buy |
69,548
+13,343
| +24% | +$6.6M | 0.01% | 1071 |
|
|
2022
Q1 | $27.6M | Sell |
56,205
-8,406
| -13% | -$3.84M | ﹤0.01% | 1409 |
|
|
2021
Q4 | $29.9M | Buy |
64,611
+24,642
| +62% | +$10.4M | ﹤0.01% | 1475 |
|
|
2021
Q3 | $14.9M | Sell |
39,969
-64,426
| -62% | -$24.5M | ﹤0.01% | 2320 |
|
|
2021
Q2 | $39.9M | Buy |
104,395
+64,937
| +165% | +$24.8M | 0.01% | 1373 |
|
|
2021
Q1 | $14.2M | Buy |
39,458
+2,710
| +7% | +$871K | ﹤0.01% | 2302 |
|
|
2020
Q4 | $11.8M | Sell |
36,748
-11,032
| -23% | -$3.39M | ﹤0.01% | 2302 |
|
|
2020
Q3 | $12.8M | Sell |
47,780
-84,769
| -64% | -$22.8M | ﹤0.01% | 1915 |
|
|
2020
Q2 | $34.9M | Buy |
132,549
+27,157
| +26% | +$7.25M | 0.01% | 1023 |
|
|
2020
Q1 | $23.9M | Buy |
105,392
+22,335
| +27% | +$6.09M | 0.01% | 1066 |
|
|
2019
Q4 | $25.1M | Sell |
83,057
-33,836
| -29% | -$9.31M | 0.01% | 1234 |
|
|
2019
Q3 | $28.1M | Buy |
116,893
+100,024
| +593% | +$27.4M | 0.01% | 1092 |
|
|
2019
Q2 | $4.76M | Buy |
16,869
+13,817
| +453% | +$3.77M | ﹤0.01% | 2779 |
|
|
2019
Q1 | $876K | Buy |
+3,052
| New | +$883K | ﹤0.01% | 5276 |
|
|
2018
Q4 | – | Sell |
-1,635
| Closed | -$450K | – | 9151 |
|
|
2018
Q3 | $448K | Sell |
1,635
-2,438
| -60% | -$633K | ﹤0.01% | 6736 |
|
|
2018
Q2 | $969K | Sell |
4,073
-8,174
| -67% | -$1.89M | ﹤0.01% | 5419 |
|
|
2018
Q1 | $2.69M | Sell |
12,247
-10,270
| -46% | -$2.41M | ﹤0.01% | 3423 |
|
|
2017
Q4 | $5.07M | Buy |
+22,517
| New | +$4.8M | ﹤0.01% | 2524 |
|
|
2017
Q2 | – | Sell |
-8,008
| Closed | -$1.44M | – | 9314 |
|
|
2017
Q1 | $1.32M | Sell |
8,008
-163,016
| -95% | -$25.9M | ﹤0.01% | 4536 |
|
|
2016
Q4 | $24.6M | Buy |
171,024
+138,576
| +427% | +$18.6M | 0.01% | 899 |
|
|
2016
Q3 | $4.07M | Sell |
32,448
-21,097
| -39% | -$2.72M | ﹤0.01% | 2488 |
|
|
2016
Q2 | $7.03M | Buy |
53,545
+46,011
| +611% | +$6.3M | ﹤0.01% | 1796 |
|
|
2016
Q1 | $1.05M | Sell |
7,534
-43,303
| -85% | -$5.79M | ﹤0.01% | 5001 |
|
|
2015
Q4 | $7.09M | Sell |
50,837
-95,145
| -65% | -$13.1M | ﹤0.01% | 2106 |
|
|
2015
Q3 | $20.4M | Sell |
145,982
-87,995
| -38% | -$13.2M | 0.01% | 1186 |
|
|
2015
Q2 | $38.4M | Buy |
233,977
+76,629
| +49% | +$12.2M | 0.02% | 840 |
|
|
2015
Q1 | $24.3M | Sell |
157,348
-99,214
| -39% | -$14.1M | 0.01% | 1095 |
|
|
2014
Q4 | $32.2M | Buy |
256,562
+49,967
| +24% | +$6.17M | 0.01% | 990 |
|
|
2014
Q3 | $24.7M | Sell |
206,595
-20,265
| -9% | -$2.32M | 0.01% | 1225 |
|
|
2014
Q2 | $24.4M | Sell |
226,860
-286,858
| -56% | -$29.6M | 0.01% | 1217 |
|
|
2014
Q1 | $51.1M | Sell |
513,718
-36,157
| -7% | -$3.27M | 0.02% | 620 |
|
|
2013
Q4 | $50.8M | Buy |
549,875
+389,022
| +242% | +$34.6M | 0.02% | 651 |
|
|
2013
Q3 | $13.4M | Sell |
160,853
-178,054
| -53% | -$15.3M | 0.01% | 1578 |
|
|
2013
Q2 | $27.7M | Buy |
+338,907
| New | +$25.4M | 0.02% | 865 |
|
Other funds holding ELV
Jeff Yass's ELV Position: Q2 2026 in Review
Jeff Yass reduced its Elevance Health (ELV) stake by 11% in Q2 2026, selling an estimated $6.25M and leaving 133,673 shares worth $51.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1479.
Jeff Yass first reported a position in ELV in Q2 2013 and has held it in 50 quarters since. The position peaked at $92.8M in Q2 2023. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Jeff Yass held 133,673 shares of Elevance Health worth $51.7M as of Q2 2026.
- Jeff Yass sold 16,856 Elevance Health shares in Q2 2026, an estimated $6.25M.
- Elevance Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #1479 holding.
- Jeff Yass first reported a position in Elevance Health in Q2 2013 and has held it in 50 quarters since.
- Jeff Yass's Elevance Health position peaked at $92.8M in Q2 2023.
- 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.